Alexithymia and dermatology: The state of the art

International Journal of Dermatology

Volumn 47, Issue 9, 2008, Pages 903-910

  Willemsen, Ria ^a,b,c   Roseeuw, Diane ^a,b,c   Vanderlinden, Johan ^a,b,c  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALEXITHYMIA; ALOPECIA AREATA; ANXIETY DISORDER; ARTICLE; ATOPIC DERMATITIS; BRAIN FUNCTION; CHILD PARENT RELATION; CHILDHOOD; CHRONIC URTICARIA; COCHRANE LIBRARY; COMORBIDITY; DEPRESSION; DERMATOLOGY; DISEASE ASSOCIATION; EMOTIONALITY; HUMAN; IMMUNITY; INTERDISCIPLINARY RESEARCH; MEDICAL RESEARCH; MEDLINE; MENTAL DISEASE; NEUROENDOCRINOLOGY; PERSONALITY; PSORIASIS; PSYCHOLOGY; PSYCHOSOMATICS; PSYCHOTHERAPY; RATING SCALE; SELF REPORT; SYMPATHETIC TONE; VITILIGO;

AFFECTIVE SYMPTOMS; ANXIETY; COMORBIDITY; DEPRESSIVE DISORDER; DERMATOLOGY; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; PSYCHOPHYSIOLOGIC DISORDERS; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; STRESS, PSYCHOLOGICAL;

EID: 50149103225     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03726.x     Document Type: Article

References (51)

1. Gupta MA, Gupta AK. Psychodermatology: An update. J Am Acad Dermatol 1996; 34: 1030-1046.
2. Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70: 118-136.
3. Arck PC, Slominski A, Theoharides TC, et al. Neuroimmunology of stress: skin takes center stage. J Invest Dermatol 2006; 12: 1697-1704.
4. Mercan S, Kivanc Altunay I. Psychodermatology: A collaborative subject of psychiatry and dermatology. Turk J Psychiatry 2006; 17: 1-9.
5. Picardi A, Pasquini P, Cattaruzza MS, et al. Psychosomatic factors in first-onset alopecia areata. Psychosomatics 2003; 44: 374-381.
6. Picardi A, Mazzotti E, Gaetano P, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics 2005; 46: 556-564.
7. Taylor GJ, Bagby RM. New trends in alexithymia research. Psychother Psychosom 2004; 73: 68-77.
8. Nemiah JC, Sifneos PE. Psychosomatic illness: A problem in communication. Psychother Psychosom 1970; 18: 154-160.
9. Sifneos PE. The prevalence of "alexithymic" characteristics in psychosomatic patients. Psychother Psychosom 1973; 22: 255-262.
10. Larsen JK, Brand N, Bermond B, et al. Cognitive and emotional characteristics of alexithymia: A review of neurobiological studies. J Psychosom Res 2003; 54: 533-541.
11. Taylor GJ, Bagby RM, Parker JDA. Affect dysregulation and alexithymia. In: Taylor GJ, Bagby RM, Parker JDA, eds. Disorders of Affect Regulation. Alexithymia in Medical and Psychiatric Illness. Cambridge: Cambridge University Press, 1997: 26-45.
12. Richards HL, Fortune DG, Griffiths CE, et al. Alexithymia in patients with psoriasis: Clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res 2005; 58: 89-96.
13. Honkalampi K, Koivumaa-Honkanen H, Antikainen R, et al. Relationships among alexithymia, adverse childhood experiences, sociodemographic variables, and actual mood disorder: A 2-year clinical follow-up study of patients with major depressive disorder. Psychosomatics 2004; 45: 197-204.
14. Kokkonen P, Karvonen JT, Veijola J, et al. Prevalence and sociodemographic correlates of alexithymia in a population sample of young adults. Compr Psychiatry 2001; 42: 471-476.
15. Mason O, Tyson M, Jones C, et al. Alexithymia: Its prevalence and correlates in a British undergraduate sample. Psychol Psychother 2005; 78: 113-125.
16. Porcelli P, Leoci C, Guerra V, et al. A longitudinal study of alexithymia and psychological distress in inflammatory bowel disease. J Psychosom Res 1996; 41: 569-573.
17. Kojima M, Frasure-Smith N, Lesperance F. Alexithymia following myocardial infarction: Psychometric properties and correlates of the Toronto Alexithymia Scale. J Psychosom Res 2001; 51: 487-495.
18. Serrano J, Plaza V, Sureda B, et al. Alexithymia: A relevant psychological variable in near-fatal asthma. Eur Respir J 2006; 28: 296-302.
19. Dewaraja R, Tanigawa T, Araki S, et al. Decreased cytotoxic lymphocyte counts in alexithymia. Psychother Psychosom 1994; 61: 199-204.
20. Burba B, Oswald R, Grigaliunien V, et al. A controlled study of alexithymia in adolescent patients with persistent somatoform pain disorder. Can J Psychol 2006; 51: 468-471.
21. Porcelli P, Bagby RM, Taylor GJ, et al. Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom Med 2003; 65: 911-918.
22. Todarello O, Casamassima A, Marinaccio M, et al. Alexithymia, immunity and cervical intraepithelial neoplasia: A pilot study. Psychother Psychosom 1994; 61: 199-204.
23. Todarello O, Casamassima A, Daniele S, et al. Alexithymia, immunity and cervical intraepithelial neoplasia: Replication. Psychother Psychosom 1997; 66: 208-213.
24. Kooiman CG, van Rees Vellinga S, Spinhoven P, et al. Childhood adversities as risk factors for alexithymia and other aspects of affect dysregulation in adulthood. Psychother Psychosom 2004; 73: 107-116.
25. Picardi A, Pasquini P, Cattaruzza MS, et al. Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J Psychosom Res 2003; 55: 189-196.
26. Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom 2003; 72: 150-158.
27. Guilbaud O, Corcos M, Hjalmarsson L, et al. Is there a psychoneuroimmunological pathway between alexithymia and immunity? Immune and physiological correlates of alexithymia. Biomed Pharmacother 2003; 57: 292-295.
28. Corcos M, Guilbaud O, Paterniti S, et al. Correlation between serum levels of interleukin-4 and alexithymia scores in healthy female subjects: Preliminary findings. Psychoneuroendocrinology 2004; 29: 686-691.
29. Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia Scale: I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994; 38: 23-32.
30. Parker JDA, Bagby RM, Taylor GJ, et al. Factorial validity of the 20-item Toronto Alexithymia Scale. Eur J Pers 1993; 7: 221-232.
31. Kooiman CG, Spinhoven P, Trijsburg RW. The assessment of alexithymia. A critical review of the literature and a psychometric study of the Toronto Alexithymia Scale-20. J Psychosom Res 2002; 53: 1083-1090.
32. Vorst HCM, Bermond B. Validity and reliability of the Bermond-Vorst Alexithymia Questionnaire. Personality and Individual Differences 2000; 30: 413-434.
33. Consoli SM, Rolhion S, Martin C, et al. Low levels of emotional awareness predict a better response to dermatological treatment in patients with psoriasis. Dermatology 2006; 212: 128-136.
34. Sayar K, Köse O, EbrinçS, et al. Hopelessness, depression and alexithymia in young Turkish soldiers suffering from alopecia areata. Dermatol Psychosom 2001; 2: 12-15.
35. Beresnevaite M. Exploring the benefits of group psychotherapy in reducing alexithymia in coronary heart disease patients: A preliminary study. Psychother Psychosom 2000; 69: 117-122.
36. Cordan Yazici A, Basterzi A, Tot Acar S, et al. Alopecia areata and alexithymia. Turk J Psychiatry 2006; 17: 101-106.
37. Richards HL, Ray DW, Kirby B, et al. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 2005; 153: 1114-1120.
38. Allegranti I, Gon T, Magaton-Rizzi G, et al. Prevalence of alexithymic characteristics in psoriatic patients. Acta Derm Venereol Suppl (Stockh) 1994; 186: 146-147.
39. Fava GA, Perini GI, Santonastaso P, et al. Life events and psychological distress in dermatological disorders: Psoriasis, chronic urticaria and alopecia. Br J Med Psychol 1980; 53: 277-282.
40. Rubino IA, Sonnino A, Stefanato CM, et al. Separation-individuation, aggression and alexithymia in psoriasis. Acta Derm Venereol Suppl (Stockh) 1989; 146: 87-90.
41. Tantam D, Kalucy R, Brown DG. Sleep, scratching and dreams in eczema. A new approach to alexithymia. Psychother Psychosom 1982; 37: 26-35.
42. Hashiro M, Okumura M. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria. J Dermatol Sci 1994; 8: 129-135.
43. Maniaci G, Epifanio MS, Marino MA, et al. The presence of alexithymia investigated by the TAS-20 in chronic urticaria patients: A preliminary report. Allerg Immunol (Paris) 2006; 38: 15-19.
44. Calikusu C, Yucel B, Polat A, et al. Expression of anger and alexithymia in patients with psychogenic excoriation: A preliminary report. Int J Psychiatry Med 2002; 32: 345-352.
45. Rowland Payne CM, Wilkinson JD, McKee PH, et al. Nodular prurigo - a clinicopathological study of 46 patients. Br J Dermatol 1985; 113: 431-439.
46. Schneider G, Hockmann J, Stander S, et al. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: Results of a case-control study. Br J Dermatol 2006; 154: 61-66.
47. Papadopoulos L, Bor R, Legg C, et al. Impact of life events on the onset of vitiligo in adults: Preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol 1998; 23: 243-248.
48. Picardi A, Porcelli P, Mazzotti E, et al. Alexithymia and global psychosocial functioning: A study on patients with skin disease. J Psychosom Res 2007; 62: 223-229.
49. Lumley MA, Ovies T, Stettner L, et al. Alexithymia, social support and health problems. J Psychosom Res 1996; 41: 519-530.
50. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: Epidemiology and management. Am J Clin Dermatol 2003; 4: 833-842.
51. Urpe M, Pallanti S, Lotti T. Psychosomatic factors in dermatology. Dermatol Clin 2005; 23: 601-608.